openPR Logo
Press release

Moderate To Severe Plaque Psoriasis Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Bristol-Myers Squibb, Akeso, Affibody, Bioeq, Can-fite Biopharma, Sinocelltech, AbbVie

10-31-2023 06:47 PM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Moderate To Severe Plaque Psoriasis Pipeline Analysis (2023)

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 30+ key pharma and biotech companies are working on 30+ pipeline drugs in the Moderate To Severe Plaque Psoriasis therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.

"Moderate To Severe Plaque Psoriasis Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Moderate To Severe Plaque Psoriasis Therapeutics Market.

The report provides a detailed description of the Moderate To Severe Plaque Psoriasis drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.

Get a Detailed Overview of the Moderate To Severe Plaque Psoriasis Clinical Trial Activities and Regulatory Developments in the domain @
https://www.delveinsight.com/report-store/moderate-to-severe-plaque-psoriasis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Moderate To Severe Plaque Psoriasis Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Moderate To Severe Plaque Psoriasis therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Moderate To Severe Plaque Psoriasis treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Moderate To Severe Plaque Psoriasis drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Moderate To Severe Plaque Psoriasis treatment market.

Learn More about the Clinical and Commercial Development Activities in the Moderate To Severe Plaque Psoriasis Therapeutics Domain @
https://www.delveinsight.com/report-store/moderate-to-severe-plaque-psoriasis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Moderate To Severe Plaque Psoriasis Therapeutics Analysis
There are approx. 30+ key companies developing the therapies for Moderate to Severe Plaque Psoriasis. Currently, Bristol-Myers Squibb is leading the therapeutics market with its Moderate to Severe Plaque Psoriasis drug candidates in the most advanced stage of clinical development.

Moderate To Severe Plaque Psoriasis Companies in the Therapeutics Market Include:
• Bristol-Myers Squibb
• Akeso Biopharma
• Jiangsu Hengrui Medicine
• Nimbus Therapeutics
• Sun Pharmaceutical Industries Limited
• Suzhou Zelgen Biopharmaceuticals
• GC Cell Corporation
• Bioeq GmbH
• Dong-A ST Co., Ltd.
• Can-fite Biopharma
• Bio-thera solutions
• AbbVie
• Sinocelltech
• Jansen research and development
• Innovent Biologics
• Aurigene discovery
• Affibody
• GlaxoSmithKline
• Abcentra
And Many Others

Emerging and Marketed Moderate To Severe Plaque Psoriasis Therapies Covered in the Report Include:
• BMS-986165 : Bristol-Myers Squibb
• AK111: Akeso Biopharma
And Many More

Get an in-depth Assessment of the Emerging Therapies and Moderate To Severe Plaque Psoriasis Companies Actively Working in the Market @
https://www.delveinsight.com/sample-request/moderate-to-severe-plaque-psoriasis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

The Report Covers the Emerging Moderate To Severe Plaque Psoriasis Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued and inactive candidates

Route of Administration
Moderate to Severe Plaque Psoriasis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Intra-articular
• Intraocular
• Intrathecal
• Intravenous
• Ophthalmic
• Oral
• Parenteral
• Subcutaneous
• Topical
• Transdermal

Molecule Type
Products have been categorized under various Molecule types such as
• Oligonucleotide
• Peptide
• Small molecule

Request for Sample PDF to Understand More About the Moderate To Severe Plaque Psoriasis Treatment Outlook and Future Perspectives @
https://www.delveinsight.com/sample-request/moderate-to-severe-plaque-psoriasis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content
1. Report Introduction
2. Executive Summary
3. Moderate To Severe Plaque Psoriasis Current Treatment Patterns
4. Moderate To Severe Plaque Psoriasis - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Moderate To Severe Plaque Psoriasis Late-Stage Products (Phase-III)
7. Moderate To Severe Plaque Psoriasis Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Moderate To Severe Plaque Psoriasis Discontinued Products
13. Moderate To Severe Plaque Psoriasis Product Profiles
14. Moderate To Severe Plaque Psoriasis Companies
15. Moderate To Severe Plaque Psoriasis Drugs
16. Dormant and Discontinued Products
17. Moderate To Severe Plaque Psoriasis Unmet Needs
18. Moderate To Severe Plaque Psoriasis Future Perspectives
19. Moderate To Severe Plaque Psoriasis Analyst Review
20. Appendix
21. Report Methodology

Get Detailed Insights About the Reports Offerings @
https://www.delveinsight.com/sample-request/moderate-to-severe-plaque-psoriasis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

------------------------------------------------------------------------------------------------------------------------------
Discover DelveInsight's Comprehensive Market Research and Consulting Services:
https://www.delveinsight.com/market-research

Elevate your industry insights with our comprehensive medical devices market assessment reports. Visit to gain a strategic edge through expert analysis and in-depth coverage of the latest trends, innovations, and market dynamics, at:
https://www.delveinsight.com/medical-devices

Empowering Cancer Care: DelveInsight's oncology consulting services offer personalized guidance and cutting-edge expertise to navigate the ongoing clinical, commercial, and regulatory developments, visit for more details:
https://www.delveinsight.com/oncology

Other Trending Healthcare Reports by DelveInsight
Aneurysmal Subarachnoid Hemorrhage (SAH) Market
https://www.delveinsight.com/report-store/aneurysmal-subarachnoid-hemorrhage-sah-market

Dupuytren's Disease Market
https://www.delveinsight.com/report-store/dupuytrens-disease-market

Homocystinuria Market
https://www.delveinsight.com/report-store/homocystinuria-market-new

Platinum-Resistant Relapsed Ovarian Cancer Market
https://www.delveinsight.com/report-store/platinum-resistant-relapsed-ovarian-cancer-market

Dementia with Diabetes Market
https://www.delveinsight.com/report-store/dementia-with-diabetes-market-forecast

Pyruvate Kinase Deficiency Market
https://www.delveinsight.com/report-store/pyruvate-kinase-deficiency-market

Uterine Serous Carcinoma Market
https://www.delveinsight.com/report-store/uterine-serous-carcinoma-market

Paraganglioma Market
https://www.delveinsight.com/report-store/paraganglioma-market

Spinal Cord Stimulators (SCS) Global Market
https://www.delveinsight.com/report-store/spinal-cord-stimulator-market

Adult Spinal Deformity Market
https://www.delveinsight.com/report-store/adult-spinal-deformity-market

Age-related Vision Dysfunction Market
https://www.delveinsight.com/report-store/age-related-vision-dysfunction-market

Erythropoietic Protoporphyria Market
https://www.delveinsight.com/report-store/erythropoietic-protoporphyria-market

Juvenile Idiopathic arthritis (JIA) Market
https://www.delveinsight.com/report-store/juvenile-idiopathic-arthritis-jia-market

Otoscope Market
https://www.delveinsight.com/report-store/otoscope-market

Surgical Energy Generators Market
https://www.delveinsight.com/report-store/surgical-energy-generators-market

Eosinophilic Esophagitis Market
https://www.delveinsight.com/report-store/eosinophilic-esophagitis-market

Hypereosinophilic Syndrome Market
https://www.delveinsight.com/report-store/hypereosinophilic-syndrome-market

Campylobacter Infections Market
https://www.delveinsight.com/report-store/campylobacter-infections-market

Degenerative Disc Disease Market
https://www.delveinsight.com/report-store/degenerative-disc-disease-ddd-market

Optic Neuritis Market
https://www.delveinsight.com/report-store/optic-neuritis-market

Shoulder Replacement Devices Global Market
https://www.delveinsight.com/report-store/shoulder-replacement-devices-market

Scleritis Market
https://www.delveinsight.com/report-store/scleritis-market

Polypoidal Choroidal Vasculopathy (PCV) Market
https://www.delveinsight.com/report-store/polypoidal-choroidal-vasculopathy-market

Post-Polycythemia Vera Myelofibrosis Market
https://www.delveinsight.com/report-store/post-polycythemia-vera-myelofibrosis-market

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Market
https://www.delveinsight.com/report-store/severe-acute-respiratory-syndrome-sars-coronavirus-infection-market

Cardiac Biomarkers Testing Devices Global Market
https://www.delveinsight.com/report-store/cardiac-biomarkers-testing-devices-market

Graves Orbitopathy Market
https://www.delveinsight.com/report-store/graves-orbitopathy-market

Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder Market
https://www.delveinsight.com/report-store/cyclin-dependent-kinase-like-5-cdkl5-deficiency-disorder-market

Febrile Neutropenia Market
https://www.delveinsight.com/report-store/febrile-neutropenia-market

Axial Spondyloarthritis Market
https://www.delveinsight.com/report-store/axial-spondyloarthritis-market

Conductive Hearing Loss Market
https://www.delveinsight.com/report-store/conductive-hearing-loss-market

Metastatic Cutaneous Squamous Cell Carcinoma Market
https://www.delveinsight.com/report-store/metastatic-cutaneous-squamous-cell-carcinoma-market

Ocular Melanoma Market
https://www.delveinsight.com/report-store/ocular-melanoma-market

Schistosomiasis Market
https://www.delveinsight.com/report-store/schistosomiasis-market

Adenosine Deaminase-Severe Combined Immunodeficiency Market
https://www.delveinsight.com/report-store/adenosine-deaminase-severe-combined-immunodeficiency-market

Dermal Erythema Market
https://www.delveinsight.com/report-store/dermal-erythema-market

Hypercalcemia Market
https://www.delveinsight.com/report-store/hypercalcemia-market

Marginal Zone Lymphoma Market
https://www.delveinsight.com/report-store/marginal-zone-lymphoma-market

Tonsillitis Market
https://www.delveinsight.com/report-store/tonsillitis-marke

Biliary Atresia Market
https://www.delveinsight.com/report-store/biliary-atresia-market

Endometrial Cancer Market
https://www.delveinsight.com/report-store/endometrial-cancer-market

Retinoblastoma Market
https://www.delveinsight.com/report-store/retinoblastoma-market

Dysautonomia (Autonomic Dysfunction) Market
https://www.delveinsight.com/report-store/dysautonomia-autonomic-dysfunction-market

IgA Nephropathy (IgAN) Market
https://www.delveinsight.com/report-store/iga-nephropathy-market

Kyphoscoliosis Market
https://www.delveinsight.com/report-store/kyphoscoliosis-market

Myofascial Pain Syndrome Market
https://www.delveinsight.com/report-store/myofascial-pain-syndrome-market

Osteogenesis Imperfecta Market
https://www.delveinsight.com/report-store/osteogenesis-imperfecta-oi-market

Treatment-Resistant Depression (TRD) Market
https://www.delveinsight.com/report-store/treatment-resistant-depression-trd-market

Fallopian Tube Cancer Market
https://www.delveinsight.com/report-store/fallopian-tube-cancer-market

Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Moderate To Severe Plaque Psoriasis Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Bristol-Myers Squibb, Akeso, Affibody, Bioeq, Can-fite Biopharma, Sinocelltech, AbbVie here

News-ID: 3271385 • Views:

More Releases from DelveInsight Business Research LLP

Genital Warts Pipeline Insights Report 2025 | DelveInsight
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight and stay ahead
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market

All 5 Releases


More Releases for Severe

Severe Acne Vulgaris or Severe Recalcitrant Nodular Acne Clinical Trials, Compan …
DelveInsight's "Severe Acne Vulgaris or Severe Recalcitrant Nodular Acne Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Severe Acne Vulgaris or Severe Recalcitrant Nodular Acne, historical and forecasted epidemiology as well as the Severe Acne Vulgaris or Severe Recalcitrant Nodular Acne market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. DelveInsight's analysis highlights that several key companies are actively
Severe Combined Immunodeficiency (SCID) Market: A Comprehensive Overview
Severe Combined Immunodeficiency (SCID) is a rare but life-threatening genetic disorder that affects the immune system, leaving individuals vulnerable to infections. It is often referred to as "bubble boy disease," due to its dramatic impact on the immune system, which fails to protect the body from pathogens. SCID can be caused by various mutations in different genes, and it leads to a complete or near-complete absence of functional T-cells and
Severe Breathing Care Ventilator Market Size 2024 to 2031.
Market Overview and Report Coverage The Severe Breathing Care Ventilator Market refers to the market for medical devices that help patients with severe breathing difficulties by providing assistance with their respiration. These ventilators are crucial in treating patients with conditions such as respiratory failure, chronic obstructive pulmonary disease (COPD), and acute respiratory distress syndrome (ARDS). The future outlook for the Severe Breathing Care Ventilator Market is very promising, with a
Severe Asthma Treatment Market - Revitalizing Quality of Life: Severe Asthma Tre …
Newark, New Castle, USA: The "Severe Asthma Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Severe Asthma Treatment Market: https://www.growthplusreports.com/report/severe-asthma-treatment-market/8939 This latest report researches the industry structure,
Severe Hypertriglyceridemia Market - Breaking Barriers in Managing Cholesterol L …
Newark, New Castle, USA: The "Severe Hypertriglyceridemia Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Severe Hypertriglyceridemia Market: https://www.growthplusreports.com/report/severe-hypertriglyceridemia-market/8763 This latest report researches the industry structure, sales, revenue,
Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H1 2017, provides an overview of the Severe Acute Respiratory Syndrome (SARS) (Infectious Disease) pipeline landscape. Severe acute respiratory syndrome (SARS) is a serious, potentially